Fig. 4From: A novel TPD52L2-ROS1 gene fusion expanding the molecular alterations in inflammatory myofibroblastic tumor: case report and literature review(A) ROS1 (Green) break-apart fluorescence in situ hybridization shows the loss of the 5’ signal (Red) in several cells, indicating positive ROS1-related fusion (arrow). (B) Sanger sequencing demonstrates that exon 4 of TPD52L2 is fused with exon 36 of ROS1.Back to article page